Ongoing or recent (within  years) evidence of autoimmune disease that required treatment with systemic immunosuppressive treatments;
Active autoimmune disease requiring disease-modifying therapy at the time of Screening.
The subject has an active autoimmune disease or a documented history of autoimmune disease or syndrome that requires systemic steroids or immunosuppressive agents
Active autoimmune disease, or documented history of autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents
The participant has an active autoimmune disease or a documented history of autoimmune disease or syndrome that requires systemic steroids or immunosuppressive agents
Presence of autoimmune disease that requires corticosteroids and/or immunosuppressive agents.
Subject has active, suspected, or previously documented autoimmune disease, defined as requiring systemic treatment.
Active autoimmune disease requiring immunosuppressive therapy
An active, known, or suspected autoimmune disease, or a documented history of autoimmune disease or syndrome, requiring systemic steroids or other immunosuppressive medications.
Patient with active autoimmune disease or any medical condition requiring the use of systemic immunosuppressive medications .
Active autoimmune condition requiring systemic immunosuppressive medication
Patients cannot have active autoimmune disease or immunosuppressive conditions
Patients with active autoimmune disease, requiring ongoing immunosuppressive therapy or history of transplantation
Uncontrolled autoimmune disease requiring active systemic treatment
Patients with active clinically significant autoimmune disease, defined as a history of requiring systemic immunosuppressive therapy and at ongoing risk for potential disease exacerbation. Patients with a history of autoimmune thyroid disease, asthma, or limited skin manifestations are potentially eligible.
Active autoimmune disease requiring systemic steroids or immunosuppressive agents within  days prior to study entry
Active autoimmune disease requiring immunosuppressive therapy
An active, known, or suspected autoimmune disease, or a documented history of autoimmune disease or syndrome, requiring systemic steroids or other immunosuppressive medications.
Active autoimmune disease requiring systemic immunosuppressive therapy
Active autoimmune disease requiring ongoing systemic immunosuppressive therapy
Active autoimmune disease requiring systemic immunosuppressive therapy
Active autoimmune disease requiring systemic immunosuppressive therapy.
Current autoimmune disease requiring >=  mg/day of prednisone or systemic immunosuppressive therapy (eg. with cyclosporine or azathioprine).
CRITERIA FOR LEUKAPHERESIS AND PRE-THERAPY EVALUATION: Active autoimmune disease requiring immunosuppressive therapy, unless considered by the PI or designee to be eligible
Active autoimmune disease requiring systemic immunosuppressive therapy
Active autoimmune disease requiring systemic immunosuppressive therapy
Active autoimmune disease requiring immunosuppressive therapy
History of chronic or recurrent (within the last year prior to enrollment) severe autoimmune or active immune-mediated disease requiring steroids or other immunosuppressive treatments.
Active autoimmune disease and chronic inflammatory conditions requiring concurrent use of any systemic immunosuppressants or steroids.
Prior organ transplant or autoimmune disease requiring immunosuppressive therapy
Active autoimmune disease requiring immunosuppressive therapy
EXCLUSION CRITERIA FOR PATIENTS WITH NSCLC OR TNBC (COHORT B): Active autoimmune disease requiring immunosuppressive therapy
EXCLUSION CRITERIA FOR TNBC: Active autoimmune disease requiring immunosuppressive therapy
Active autoimmune disease requiring disease-modifying therapy
History of severe autoimmune disease requiring steroids or other immunosuppressive treatments
Have any active disease requiring systemic immunosuppressive treatment
Autoimmune disorders on current immunosuppressive therapy
Patients must not have a history of, or currently active autoimmune disorders requiring cytotoxic or immunosuppressive therapy, or autoimmune disorders with visceral involvement
Any prior autoimmune disorders requiring cytotoxic or immunosuppressive therapy or autoimmune disorders with visceral involvement
Active autoimmune disease requiring systemic immunosuppressive therapy
Active autoimmune disease requiring systemic immunosuppressive therapy
Patients must not have a history of, or currently active autoimmune disorders requiring cytotoxic or immunosuppressive therapy, or autoimmune disorders with visceral involvement
An active, known, or suspected autoimmune disease, or a documented history of autoimmune disease or syndrome, requiring systemic steroids or other immunosuppressive medications.
Active autoimmune disease requiring systemic immunosuppressive therapy
Active autoimmune disease requiring immunosuppressive treatment or history of autoimmune disease requiring immunosuppressive therapy (e.g. requirement for systemic therapy with > mg/day prednisone-equivalent) or any other concurrent use of immunosuppressive therapy.
No history of autoimmune disease requiring systemic therapy (e.g. steroids or biologic agents)
Active autoimmune disease requiring systemic immunosuppressive therapy
Autoimmune disorders on current immunosuppressive therapy
Has an active autoimmune disease requiring systemic treatment within the past  months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents.
Active (as defined by requiring immunosuppressive therapy) or history of clinically significant autoimmune disease (as defined by previously requiring immunosuppressive therapy)
Active autoimmune disease requiring systemic immunosuppressive therapy
Patients with a history of autoimmune disease that require immunosuppressive medications at the time of screening are excluded
Active autoimmune disease requiring systemic treatment within the past  months or documented history of clinically severe autoimmune disease, or syndrome that requires systemic steroids or immunosuppressive agents.
Participant has documented history of autoimmune disease or syndrome that currently requires systemic steroids or immunosuppressive agents
Active or history of any autoimmune disease (except for subjects with vitiligo) or immunodeficiencies that required treatment with systemic immunosuppressive drugs
Subject has an active autoimmune disease or a documented history of autoimmune disease or syndrome that requires systemic steroids or immunosuppressive agents
History of chronic or recurrent (within the last year prior to enrollment) severe autoimmune or active immune-mediated disease requiring steroids or other immunosuppressive treatments.
No disease requiring systemic immunosuppressive therapy
Active autoimmune disease requiring disease modifying therapy
Active autoimmune disease, or a documented history of autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents
Patients on immunosuppressive therapy or with immune system disorders, including autoimmune disease
Subjects with any major autoimmune diseases or autoimmune disorders requiring systemic iv/oral steroids or immunosuppressive or immunomodulatory therapies.
Patients with active autoimmune disease requiring disease-modifying therapy.
Subjects with active autoimmune disease requiring systemic immunosuppressive treatment within the past  weeks such as but not restricted to inflammatory bowel disease, systemic lupus erythematosus, ankylosing spondylitis, scleroderma, or multiple sclerosis; a history of autoimmune disease which is not active nor has required recent systemic immunosuppressive therapy (<  weeks prior to enrollment) is not reason for exclusion
Participants who have an active autoimmune disease requiring systemic treatment within the past  months or have a documented history of clinically severe autoimmune disease that requires systemic steroids or immunosuppressive agents.
The participant has an active autoimmune disease or a documented history of autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents.
Active autoimmune disease requiring systemic treatment within the past  months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic or immunosuppressive agents
Active autoimmune disease requiring systemic treatment within the past  months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents
Active autoimmune disease requiring systemic immunosuppressive therapy
Active autoimmune/inflammatory conditions requiring ongoing immunosuppressive therapy
Prior allogeneic transplant . History of severe autoimmune disease requiring steroids or other immunosuppressive treatments.
Active autoimmune disease currently requiring therapy
Any immunodeficiency disease or immunocompromised state or active autoimmune disease or history of autoimmune disease requiring systemic steroids or other immunosuppressive treatment
History of severe autoimmune disease requiring steroids or other immunosuppressive treatments
Patients with active autoimmune disease requiring disease-modifying therapy.
Subjects with active autoimmune disease or a history of autoimmune disease requiring systemic steroids or other immunosuppressive treatment.
Active autoimmune disease or any medical condition requiring the use of systemic immunosuppressive medications;
DONOR: Autoimmune disease requiring immunosuppressive drugs for maintenance
Active autoimmune disease or condition requiring chronic immunosuppressive therapy
Has an active autoimmune disease requiring systemic treatment within the past  months or a documented history of clinically severe autoimmune disease, or a syndrome that requires systemic steroids or immunosuppressive agents.
Documented history of severe autoimmune or immune mediated symptomatic disease that required prolonged (more than  months) systemic immunosuppressive (ie, steroids) treatment
Autoimmune disease requiring immunosuppressive drugs for maintenance
DONOR: Autoimmune disease requiring immunosuppressive drugs for maintenance
Known history or evidence of brain metastases, immunodeficiency disease or immunocompromised state or history of autoimmune disease requiring systemic steroids or other immunosuppressive treatment
No active (as defined by requiring immunosuppressive therapy) or history of clinically significant autoimmune disease (as defined by previously requiring immunosuppressive therapy)
Ongoing or recent (within  years) evidence of significant autoimmune disease that required treatment with systemic immunosuppressive treatments
Any immunodeficiency disease or immunocompromised state or active autoimmune disease or history of autoimmune disease requiring systemic steroids or other immunosuppressive treatment
Active autoimmune disease requiring disease modifying therapy
Subject has history of chronic or recurrent (within the last year prior to screening) severe autoimmune or immune mediated disease requiring steroids or other immunosuppressive treatments.
Patients with active autoimmune conditions requiting systemic immunosuppressive therapy within the previous  years at not eligible
Patients with active autoimmune conditions requiring systemic immunosuppressive therapy within the previous  years are not eligible
Patients with active autoimmune conditions requiring systemic immunosuppressive therapy within the previous  years are not eligible
Active autoimmune disease requiring systemic immunosuppressive therapy (standard of care [SOC] GVHD prophylaxis is permitted)
Documented or suspected immunosuppressive disorder or autoimmune disease
Known immunosuppressive disease, autoimmune conditions, and /or chronic viral infections
Subjects with an active or recent history of a known or suspected autoimmune disease or recent history of a syndrome that required systemic corticosteroids/immunosuppressive medications